Philip Vickers is the founder of Faze Medicines. Faze Medicines has raised $81M in total funding. Latest round: Series A. Based in Cambridge, USA.
Philip Vickers, Ph.D., is the Co-founder and former CEO of Faze Medicines, a biotechnology startup founded in 2020 that developed therapies targeting biomolecular condensates. The company launched with an $81 million Series A round in December 2020 but quietly shut down in 2022. Vickers is currently the President and CEO of Solu Therapeutics.
Full founder directory · Investor directory · Company funding database · Fundraising library